Instil Bio Files 8-K for Material Agreement

Ticker: TIL · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1789769

Instil Bio, INC. 8-K Filing Summary
FieldDetail
CompanyInstil Bio, INC. (TIL)
Form Type8-K
Filed DateMar 31, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, corporate-filing, financials

TL;DR

Instil Bio filed an 8-K on 3/28/25 for a material agreement.

AI Summary

Instil Bio, Inc. filed an 8-K on March 28, 2025, reporting a material definitive agreement and financial statements. The filing details Instil Bio's corporate information, including its address in Dallas, Texas, and its fiscal year end of December 31.

Why It Matters

This filing indicates a significant contractual development for Instil Bio, Inc., which could impact its operations and financial standing.

Risk Assessment

Risk Level: low — The filing is a standard corporate disclosure and does not contain information suggesting immediate or significant risk.

Key Numbers

Key Players & Entities

FAQ

What is the nature of the material definitive agreement filed by Instil Bio, Inc.?

The filing indicates a 'Material Definitive Agreement' was entered into, but the specific details of this agreement are not provided in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on March 28, 2025.

Where are Instil Bio, Inc.'s principal executive offices located?

Instil Bio, Inc.'s principal executive offices are located at 3963 Maple Avenue, Suite 350, Dallas, Texas 75219.

What is Instil Bio, Inc.'s SIC code and industry classification?

Instil Bio, Inc.'s Standard Industrial Classification (SIC) code is 2836, for Biological Products (no diagnostic substances).

What is the Commission File Number for Instil Bio, Inc.?

Instil Bio, Inc.'s Commission File Number is 001-40215.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding Instil Bio, Inc. (TIL).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing